Intuitive Surgical, Inc. (ISRG) Guidance & Earnings Results
On 2026-10-20 Intuitive Surgical, Inc. reaffirmed guidance: "FY26 da Vinci procedure growth ~14-15% (closer to midpoint); non-GAAP gross margin 68.7-69.3%; non-GAAP opex growth…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
ISRGIntuitive Surgical, Inc.Follow ISRG — free
—
Price chart with a free account
- Market cap
- 156.8B
- P/E TTM
- 54.8
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 20 Jan, in 88 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 20 Oct 26 | Reaffirmed | FY26 da Vinci procedure growth ~14-15% (closer to midpoint); non-GAAP gross margin 68.7-69.3%; non-GAAP opex growth 11-13%. · full year |
| 16 Jul 26 | Reaffirmed | FY2026 worldwide da Vinci procedure growth approximately 13.5% to 15.5%; non-GAAP gross profit margin 68.0% to 69.0%; non-GAAP operating expense growth 11% to 13% · full year |
| 21 Apr 26 | Reaffirmed | FY2026 da Vinci procedure growth 13.5%-15.5%; non-GAAP gross margin 67.5%-68.5%; operating expense growth 11%-14% · full year |
| 22 Jan 26 | Reaffirmed | 2026 procedure growth 13-15%; gross margin 67-68%; opex growth 11-15% |
| 21 Oct 25 | Raised | da Vinci procedure growth guidance raised to ~17-17.5% from 17% · full year |
Intuitive Surgical, Inc. — questions
- What guidance did Intuitive Surgical, Inc. give?
- On 2026-10-20: "FY26 da Vinci procedure growth ~14-15% (closer to midpoint); non-GAAP gross margin 68.7-69.3%; non-GAAP opex growth 11-13%."
- When does Intuitive Surgical, Inc. report earnings?
- Intuitive Surgical, Inc.'s next earnings report is expected on 2027-01-20.
Every figure on this page comes from Intuitive Surgical, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.